Wegovy 1mg FlexTouch

Wegovy 1 mg FlexTouch: Product Details & SEO Guide

Product Overview

Wegovy (semaglutide) 1 mg is a mid-strength dose of the once-weekly GLP-1 receptor agonist. This dose is typically prescribed during the third month of treatment. It serves as a bridge between the lower starter doses and the higher maintenance doses (1.7 mg and 2.4 mg) required for maximum weight loss efficacy.

Technical Specifications

• Brand Name: Wegovy®

• Delivery System: FlexTouch® multidose pen

• Active Ingredient: Semaglutide

• Dosage Strength: 1 mg

• Color Coding: The 1 mg pen and packaging typically feature a teal/light blue color scheme to distinguish it from other strengths.

• Administration: Weekly subcutaneous injection.

MORE WEIGHTLOSS PRODUCT

 The Transition to Wegovy 1 mg:

Explain that this dose is the “ramp-up” phase. It builds the concentration of semaglutide in the blood to further suppress appetite.

What to Expect at Month 3:

Discuss clinical expectations. Many patients begin to see more significant, visible weight loss results at this stage compared to the 0.25 mg or 0.5 mg doses.

Managing Side Effects at 1 mg:

As the dose increases, some patients experience a recurrence of gastrointestinal issues. Provide tips (e.g., eating smaller meals, staying hydrated).

Storage and Handling:

Remind users to keep the FlexTouch pen refrigerated ($2^\circ\text{C} – 8^\circ\text{C}$).